摘要
该研究调查了阿尔茨海默病(AD)与年龄相关的黄斑变性(AMD)的迹象。这些衰老相关疾病主要影响中枢神经系统的不同部分,但实质上类似于异常细胞代谢和氧化应激、神经炎症和微血管异常。而AMD是视网膜疾病,据报道, 阿尔茨海默病不仅影响大脑还视网膜,Aβ细胞、神经退化和血管的变化。关于阿尔茨海默病和AMD研究基于人口众多为疾病的提供了相互矛盾的结果。 本研究调查了AMD一个小的迹象,但非常实验澳大利亚成像生物标志物的特征和生活方式研究衰老的(AIBL)。实验由22例(70.2±9.0岁,年龄13岁男,9女)和101年认知正常(CN)参与者(71.3±6.0岁,40岁男性,61名女性)组成。 与CN组相比, 阿尔茨海默病组有更大比例的参与者与早期AMD(p < 0.0001,优势比为18.67,95%可信区间4.42 - 78.80)。物流模型对早期AMD发现重大阿尔茨海默病进行了诊断(p < 0.0001),在调整了混杂因素(年龄、吸烟、高血压、高、低密度脂蛋白,白内障手术和APOEε4载体状态)。 这项研究的结果的与AMD和阿尔茨海默病的风险增加是一致。虽然这些疾病的病理生理学是不清楚,理解它们之间的特性可以提供进一步的认识,并可能导致加速对其发病机理和治疗这两种疾病研究的发展。
关键词: 老化、诊断、阿尔茨海默氏病、视网膜、眼睛、视力障碍。
Current Alzheimer Research
Title:Alzheimer’s Disease and the Early Signs of Age-Related Macular Degeneration
Volume: 13 Issue: 11
Author(s): Shaun Frost, Robyn Guymer, Khin Zaw Aung, S. Lance Macaulay, Hamid R Sohrabi, Pierrick Bourgeat, Olivier Salvado and Christopher C. Rowe, David Ames, Colin L. Masters, Ralph N. Martins, Yogesan Kanagasingam, the AIBL Research Group
Affiliation:
关键词: 老化、诊断、阿尔茨海默氏病、视网膜、眼睛、视力障碍。
摘要: This study investigated signs of age related macular degeneration (AMD) in Alzheimer’s disease (AD). These age-related diseases primarily affect different parts of the central nervous system but are substantially similar in terms of abnormal extracellular deposits, metabolic and oxidative stress, neuroinflammation and microvascular abnormalities. While AMD is a retinal disease, AD is reported to affect not only the brain but also the retina, with Aβ deposits, neurodegeneration and vascular changes. Large population based studies have provided conflicting results regarding the comorbidity of AD and AMD.
This study investigated signs of AMD in a small but well characterized cohort from the Australian Imaging Biomarkers and Lifestyle study of aging (AIBL). The cohort consisted of 22 AD patients (age 70.2 ± 9.0 yrs, 13 male, 9 female) and 101 cognitively normal (CN) participants (age 71.3 ± 6.0 yrs, 40 male, 61 female).
In comparison with the CN group, the AD group had a greater proportion of participants with early AMD (p < 0.0001, odds ratio 18.67, 95% CI 4.42 – 78.80). A logistic model for early AMD found a significant association with AD diagnosis (p < 0.0001), after adjusting for confounders (age, smoking, hypertension, high and low density lipoproteins, cataract surgery and APOE ε4 carrier status).
The results of this study are consistent with an increased risk of AMD in AD. While the pathophysiology of these diseases are unclear, understanding the shared features between them may provide further knowledge about their pathogenesis and could lead to accelerated development of therapies for both diseases.
Export Options
About this article
Cite this article as:
Shaun Frost, Robyn Guymer, Khin Zaw Aung, S. Lance Macaulay, Hamid R Sohrabi, Pierrick Bourgeat, Olivier Salvado and Christopher C. Rowe, David Ames, Colin L. Masters, Ralph N. Martins, Yogesan Kanagasingam, the AIBL Research Group , Alzheimer’s Disease and the Early Signs of Age-Related Macular Degeneration, Current Alzheimer Research 2016; 13 (11) . https://dx.doi.org/10.2174/1567205013666160603003800
DOI https://dx.doi.org/10.2174/1567205013666160603003800 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease
Current Genomics A New “Era” for the α7-nAChR
Current Drug Targets Rivastigmine for Refractory REM Behavior Disorder in Mild Cognitive Impairment
Current Alzheimer Research Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Current Respiratory Medicine Reviews Human Cognitive and Neuro-Psychiatric Bio-Markers in the Cardiac Peri-Operative Patient
Current Molecular Medicine Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Conference Report:5<sup>th</sup> International Conference on Nanotek & Expo, Nov 16-18, 2015, San Antonio TX, USA
CNS & Neurological Disorders - Drug Targets Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design Antithrombin, an Important Inhibitor in Blood Clots
Current Topics in Medicinal Chemistry Reduction of Myocardial Ischemia-Reperfusion Injury with Pre- and Postconditioning: Molecular Mechanisms and Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets Current Advances in Vehicles for Brain Gene Delivery
Current Gene Therapy The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety Lithium - Pharmacological and Toxicological Aspects: The Current State of the Art
Current Medicinal Chemistry Identification of Novel Quantitative Traits-Associated Susceptibility Loci for APOE ε 4 Non-Carriers of Alzheimer’s Disease
Current Alzheimer Research Review About Ginkgo Biloba Special Extract EGb 761 (Ginkgo)
Current Pharmaceutical Design The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases
CNS & Neurological Disorders - Drug Targets Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology Long non-coding RNAs in Alzheimer’s disease
Current Topics in Medicinal Chemistry Medicinal Chemistry of Potassium Channel Modulators: An Update of Recent Progress (2011-2017)
Current Medicinal Chemistry Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients
Current Alzheimer Research